trastuzumab-MC-vc-PAB-MMAF

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nametrastuzumab-MC-vc-PAB-MMAF

Drug Alias Nametrastuzumab-vc-MMAFtrastuzumab-vc-monomethyl auristatin phenylalaninetmab-vc-MMAFtrastuzumab-vc-MMAF antibody-drug conjugate (Genentech)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate

Mechanisms of ActionTubulin inhibitors

TargetsTubulin

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGenentech Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGenentech Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A